Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | GLI1 | P08151 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20095979 | 1.00 | BCHE (0.36) | BCHEGLI1DPP4OPRL1OPRM1 | |
| SCHEMBL15386556 | 0.87 | CYP3A4 (0.41) | BCHEGLI1DPP4OPRL1CASP3 | |
| SCHEMBL3930922 | 0.87 | CYP3A4 (0.41) | BCHEGLI1DPP4OPRL1CASP3 | |
| SCHEMBL8260203 | 0.87 | CYP3A4 (0.41) | BCHEGLI1DPP4OPRL1CASP3 | |
| SCHEMBL8261848 | 0.85 | CYP3A4 (0.37) | BCHEGLI1DPP4OPRL1CASP3 | |
| SCHEMBL14434721 | 0.85 | CYP3A4 (0.37) | BCHEGLI1DPP4OPRL1CASP3 | |
| SCHEMBL23195784 | 0.84 | — | — | |
| SCHEMBL2921240 | 0.82 | BCHE (0.32) | BCHEGLI1 | |
| SCHEMBL2921241 | 0.81 | GLI1 (0.40) | BCHEGLI1DPP4OPRL1OPRM1 | |
| SCHEMBL20063339 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018072602-A1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2018-04-26 | — | — | WO | disclosed |